USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT.
Autor: | Senegaglia, AC1 (AUTHOR), Rebelatto, CLK1 (AUTHOR), Franck, CL2 (AUTHOR), Lima, JS3 (AUTHOR), Daga, DR1 (AUTHOR), Shigunov, P4 (AUTHOR), Azambuja, AP1 (AUTHOR), Bana, EG3 (AUTHOR), Marsaro, DB1 (AUTHOR), Schaidt, B1 (AUTHOR), Micosky, A1 (AUTHOR), Jamur, VR1 (AUTHOR), Vaz, IM1 (AUTHOR), Schluga, Y2 (AUTHOR), Leite, LMB1 (AUTHOR), Ribeiro, LL3 (AUTHOR), Correa, A4 (AUTHOR), Brofman, PRS1 (AUTHOR) |
---|---|
Zdroj: | Cytotherapy (Elsevier Inc.). Apr2021 Supplement, Vol. 23, p38-39. 2p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |